FLT3 and acute myeloid leukemia: Animal models of NPMc+ AML, aiming at understanding the NPM1-driven leukemogenesis, have thus far revealed that NPMc+ alone displays low leukemogenic activity [8, 9] and that additional cooperative mutations, such as FLT3-ITD [10] or N-ras mutations [9] are required for AML to develop.